Biogen (BIIB.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec4

Biogen CEO Purchases Company Stock

20:06

Dec3

Biogen advances immunology pipeline, felzartamab shows promise in multiple diseases

20:37

Dec2

Biogen and Eisai Showcase LEQEMBI's Pharmacological Effect on Alzheimer's Patients

21:41

Dec1

Stoke Therapeutics and Biogen to Present New Clinical Data on Zorevunersen at AES Annual Meeting

12:30

Nov30

Biogen Collaborates with Dayra on Oral Macrocyclic Peptides for Immune Diseases

05:32

Nov28

Biogen and Eisai seek Japan approval for home Alzheimer's drug injection

12:43

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.535 B, Net Income 466.5 M, EPS 3.17

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.646 B, Net Income 634.8 M, EPS 4.33

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.431 B, Net Income 240.5 M, EPS 1.64

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change